Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
When indolent follicular lymphoma is not indolent.
Tang T, Martin P. Tang T, et al. Leuk Lymphoma. 2014 Nov;55(11):2417-8. doi: 10.3109/10428194.2014.927462. Epub 2014 Jun 25. Leuk Lymphoma. 2014. PMID: 24882260 No abstract available.
Role of Surveillance Imaging in Patients With Peripheral T-Cell Lymphoma.
Tang T, Chen Z, Praditsuktavorn P, Khoo LP, Ruan J, Lim ST, Tan D, Phipps C, Lee YS, Goh YT, Hwang W, Tao M, Quek R, Farid M, Furman RR, Leonard JP, Martin P. Tang T, et al. Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):117-21. doi: 10.1016/j.clml.2015.12.006. Epub 2015 Dec 21. Clin Lymphoma Myeloma Leuk. 2016. PMID: 26796979
The impact of time from diagnosis to treatment in diffuse large B-cell lymphoma.
Phipps C, Lee YS, Ying H, Nagarajan C, Grigoropoulos N, Chen Y, Tang T, Goh AZ, Ghosh A, Ng HJ, Gopalakrishnan S, Loh Y, Lim ST, Hwang W, Tan D, Goh YT. Phipps C, et al. Among authors: tang t. Leuk Lymphoma. 2018 Oct;59(10):2336-2341. doi: 10.1080/10428194.2017.1422863. Epub 2018 Jan 18. Leuk Lymphoma. 2018. PMID: 29345210
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma.
Tang T, Martin P, Somasundaram N, Lim C, Tao M, Poon E, Yunon MJ, Toh SQ, Yan SX, Farid M, Chan JY, Lim ST. Tang T, et al. Haematologica. 2021 Dec 1;106(12):3170-3175. doi: 10.3324/haematol.2020.251454. Haematologica. 2021. PMID: 33147935 Free PMC article. Clinical Trial.
Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease.
Lim SH, Hong JY, Lim ST, Hong H, Arnoud J, Zhao W, Yoon DH, Tang T, Cho J, Park S, Ko YH, Kim SJ, Suh C, Lin T, Kim WS. Lim SH, et al. Among authors: tang t. Ann Oncol. 2017 Sep 1;28(9):2199-2205. doi: 10.1093/annonc/mdx316. Ann Oncol. 2017. PMID: 28911074 Free article.
Cell-of-origin and bone marrow involvement increase specificity of defining patients with diffuse large B-cell lymphoma at high risk of CNS relapse: a study of 793 patients treated with chemoimmunotherapy in Asia.
Ong SY, Phipps C, Nagarajan C, Tang T, Lim ST, Goh YT, Lee YS. Ong SY, et al. Among authors: tang t. Leuk Lymphoma. 2020 Jan;61(1):225-227. doi: 10.1080/10428194.2019.1648805. Epub 2019 Aug 5. Leuk Lymphoma. 2020. PMID: 31379229 No abstract available.
5,315 results